Literature DB >> 8406596

Polyclonal anti-idiotypes induce antibody responses protective against ricin cytotoxicity.

T C Chanh1, J F Hewetson.   

Abstract

Protein G-purified goat anti-ricin IgG, previously demonstrated to protect against ricin toxicity in vitro and in vivo, was used to raise BALB/c mouse and New Zealand White rabbit polyclonal anti-idiotypic antibodies. The generated anti-idiotypic sera were repeatedly absorbed over agarose conjugated to normal goat immunoglobulins, and purified by protein A-agarose affinity chromatography. Immunization of BALB/c mice with BALB/c anti-idiotypes did not result in a significant anti-ricin antibody response. However, injection of BALB/c mice with BALB/c anti-idiotypes conjugated to keyhole limpet haemocyanin (KLH) or with unconjugated rabbit anti-idiotypes resulted in specific and anti-ricin immune responses. The anti-idiotype-induced anti-ricin antibody responses protected against the in vitro cytotoxicity of ricin, a potent plant-derived protein synthesis inhibitor, as assessed by the murine EL-4 leukaemia cell assays. Thus, anti-idiotype-based vaccines may represent an alternative, safe and effective means of inducing protective immunity against toxins such as ricin, whose extreme in vivo toxicity render them unsafe as immunogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406596      PMCID: PMC1421923     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Mechanism of cell entry and toxicity of an affinity- purified lectin from Ricinus communis and its differential effects on normal and virus-transformed fibroblasts.

Authors:  G L Nicolson; M Lacorbiere; T R Hunter
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701

2.  Anti-idiotypic antibodies against a monoclonal antibody specific for the trichothecene mycotoxin T-2.

Authors:  T C Chanh; R I Huot; M R Schick; J F Hewetson
Journal:  Toxicol Appl Pharmacol       Date:  1989-09-01       Impact factor: 4.219

3.  Production and characterization of anti-idiotypic antibody reagents.

Authors:  M R Schick; R C Kennedy
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

4.  The interaction of Ricinus communis agglutinin with normal and tumor cell surfaces.

Authors:  G L Nicolson; J Blaustein
Journal:  Biochim Biophys Acta       Date:  1972-05-09

5.  Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis.

Authors:  S Olsnes; A Pihl
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

6.  Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production.

Authors:  A Nisonoff; E Lamoyi
Journal:  Clin Immunol Immunopathol       Date:  1981-12

7.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

8.  In vitro and in situ inhibition of the sodium channel blocker saxitoxin by monoclonal antibodies.

Authors:  R I Huot; D L Armstrong; T C Chanh
Journal:  J Toxicol Environ Health       Date:  1989

9.  Monoclonal anti-idiotype induces protection against the cytotoxicity of the trichothecene mycotoxin T-2.

Authors:  T C Chanh; G Rappocciolo; J F Hewetson
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

10.  Monoclonal antibody prophylaxis against the in vivo toxicity of ricin in mice.

Authors:  T C Chanh; M J Romanowski; J F Hewetson
Journal:  Immunol Invest       Date:  1993-02       Impact factor: 3.657

View more
  2 in total

Review 1.  Yeast killer systems.

Authors:  W Magliani; S Conti; M Gerloni; D Bertolotti; L Polonelli
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Idiotypic modulation of the antibody response of mice to Echinococcus granulosus antigens.

Authors:  A Baz; A Hernández; S Dematteis; H Carol; A Nieto
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.